CCR2 receptor ligands inhibit Cav3.2 T-type calcium channels

Molecular Pharmacology

Volumn 77, Issue 2, 2010, Pages 211-217

  You, Haitao ^a   Altier, Christophe ^a   Zamponi, Gerald W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL T TYPE; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR2; LIGAND; METAL ION; MONOCYTE CHEMOTACTIC PROTEIN 1; PENTETIC ACID; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM CURRENT; CONTROLLED STUDY; DENATURATION; DISSOCIATION; EMBRYO; HEAT; HUMAN; HUMAN CELL; NERVE CELL; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPINAL GANGLION; WHOLE CELL;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CALCIUM CHANNELS, T-TYPE; CELL LINE; CHEMOKINE CCL2; HUMANS; LIGANDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CCR2;

EID: 74549143847     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.059022     Document Type: Article

References (40)

1. Abbadie C, Bhangoo S, De Koninck Y, Malcangio M, Melik-Parsadaniantz S, and White FA (2009) Chemokines and pain mechanisms. Brain Res Rev 60:125-134.
2. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, and Forrest MJ (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A 100:7947-7952.
3. Altier C, Dale CS, Kisilevsky AE, Chapman K, Castiglioni AJ, Matthews EA, Evans RM, Dickenson AH, Lipscombe D, Vergnolle N, and Zamponi GW (2007) Differential role of N-type calcium channel splice isoforms in pain. J Neurosci 27:6363-6373.
4. Altier C, Khosravani H, Evans RM, Hameed S, Peloquin JB, Vartian BA, Chen L, Beedle AM, Ferguson SS, Mezghrani A, Dubel SJ, Bourinet E, McRory JE, and Zamponi GW (2006) ORL1 receptor-mediated internalization of N-type calcium channels. Nat Neurosci 9:31-40.
5. 2+ channels to treat pain: T-type versus N-type. Trends Pharmacol Sci 25:465-470.
6. Belardetti F and Zamponi GW (2008) Linking calcium-channel isoforms to potential therapies. Curr Opin Investig Drugs 9:707-715.
7. Beedle AM, Hamid J, and Zamponi GW (2002) Inhibition of transiently expressed low- and high-voltage-activated calcium channels by trivalent metal cations. J Membr Biol 187:225-238.
8. Beedle AM, McRory JE, Poirot O, Doering CJ, Altier C, Barrere C, Hamid J, Nargeot J, Bourinet E, and Zamponi GW (2004) Agonist-independent modulation of N-type calcium channels by ORL1 receptors. Nat Neurosci 7:118-125.
9. Bourinet E, Alloui A, Monteil A, Barrère C, Couette B, Poirot O, Pages A, McRory J, Snutch TP, Eschalier A, and Nargeot J (2005) Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24:315-324.
10. Cherney RJ, Mo R, Meyer DT, Nelson DJ, Lo YC, Yang G, Scherle PA, Mandlekar S, Wasserman ZR, Jezak H, Solomon KA, Tebben AJ, Carter PH, and Decicco CP (2008) Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists. J Med Chem 51:721-724.
11. Dansereau MA, Gosselin RD, Pohl M, Pommier B, Mechighel P, Mauborgne A, Rostene W, Kitabgi P, Beaudet N, Sarret P, and Melik-Parsadaniantz S (2008) Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem 106:757-769.
12. 2+ channel inhibition by G protein β2γ2 subunits. Proc Natl Acad Sci U S A 103:14590-14595.
13. Feng ZP, Doering CJ, Winkfein RJ, Beedle AM, Spafford JD, and Zamponi GW (2003) Determinants of inhibition of transiently expressed voltage-gated calcium channels by ω-conotoxins GVIA and MVIIA. J Biol Chem 278:20171-20178.
14. Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ, Park JY, Lind AL, Ma Q, and Ji RR (2009) JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 29:4096-4108.
15. Iftinca M, Hamid J, Chen L, Varela D, Tadayonnejad R, Altier C, Turner RW, and Zamponi GW (2007) Regulation of T-type calcium channels by Rho-associated kinase. Nat Neurosci 10:854-860.
16. Jung H, Bhangoo S, Banisadr G, Freitag C, Ren D, White FA, and Miller RJ (2009) Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. J Neurosci. 29:8051-8062.
17. Kang HW, Park JY, Jeong SW, Kim JA, Moon HJ, Perez-Reyes E, and Lee JH (2006) A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels. J Biol Chem 281:4823-4830.
18. Kisilevsky AE and Zamponi GW (2008) D2 dopamine receptors interact directly with N-type calcium channels and regulate channel surface expression levels. Channels (Austin) 2:269-277.
19. Kisilevsky AE, Mulligan SJ, Altier C, Iftinca MC, Varela D, Tai C, Chen L, Hameed S, Hamid J, Macvicar BA, and Zamponi GW (2008) D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry. Neuron 58:557-570.
20. Magga JM, Jarvis SE, Arnot MI, Zamponi GW, and Braun JE (2000) Cysteine string protein regulates G protein modulation of N-type calcium channels. Neuron 28: 195-204.
21. Matthews EA and Dickenson AH (2001) Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats. Eur J Pharmacol 415:141-149.
22. Mintz IM (1994) Block of Ca channels in rat central neurons by the spider toxin ω-Aga-IIIA. J Neurosci 14:2844-2853.
23. Mirzadegan T, Diehl F, Ebi B, Bhakta S, Polsky I, McCarley D, Mulkins M, Weatherhead GS, Lapierre JM, Dankwardt J, Morgans D, Jr., Wilhelm R, and Jarnagin K (2000) Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J Biol Chem 275:25562-25571.
24. Negri L, Lattanzi R, Giannini E, Colucci M, Margheriti F, Melchiorri P, Vellani V, Tian H, De Felice M, and Porreca F (2006) Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J Neurosci 26:6716-6727.
25. Nelson MT, Joksovic PM, Su P, Kang HW, Van Deusen A, Baumgart JP, David LS, Snutch TP, Barrett PQ, Lee JH, Zorumski CF, Perez-Reyes E, and Todorovic SM (2007) Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J Neurosci 27:12577-12583.
26. 2+ channel. EMBO J 20:2349-2356.
27. Sidach SS and Mintz IM (2002) Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels. J Neurosci 22:2023-2034.
28. Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR, Mayo M, McGuire D, and Ellis D (2004) Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 291:63-70.
29. Tanaka T, Minami M, Nakagawa T, and Satoh M (2004) Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res 48:463-469.
30. Tedford HW and Zamponi GW (2006) Direct G protein modulation of Cav2 calcium channels. Pharmacol Rev 58:837-862.
31. Thacker MA, Clark AK, Bishop T, Grist J, Yip PK, Moon LD, Thompson SW, Marchand F, and McMahon SB (2009) CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 13:263-272.
32. Todorovic SM and Jevtovic-Todorovic V (2007) Regulation of T-type calcium channels in the peripheral pain pathway. Channels (Austin) 1:238-245.
33. Traboulsie A, Chemin J, Chevalier M, Quignard JF, Nargeot J, and Lory P (2007) Subunit-specific modulation of T-type calcium channels by zinc. J Physiol 578: 159-171.
34. White FA, Bhangoo SK, and Miller RJ (2005a) Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov 4:834-844.
35. White FA, Sun J, Waters SM, Ma C, Ren D, Ripsch M, Steflik J, Cortright DN, Lamotte RH, and Miller RJ (2005b) Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci U S A 102:14092-14097.
36. White FA, Jung H, and Miller RJ (2007) Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci U S A 104:20151-20158.
37. Wolfe JT, Wang H, Howard J, Garrison JC, and Barrett PQ (2003) T-type calcium channel regulation by specific G-protein βγ subunits. Nature 424:209-213.
38. Zamponi GW, Lewis RJ, Todorovic SM, Arneric SP, and Snutch TP (2009) Role of voltage-gated calcium channels in ascending pain pathways. Brain Res Rev 60: 84-89.
39. Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, and Rivest S (2007) Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 27:12396-12406.
40. Zhang J and De Koninck Y (2006) Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J Neurochem 97:772-783.